Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5037)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2014 (publication date) through May 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh N, Jindal A, Behera D. Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature. World J Clin Oncol 2014; 5(5): 858-864 [PMID: 25493223 DOI: 10.5306/wjco.v5.i5.858] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i5/858.htm |
| Number | Citing Articles |
| 1 |
Kumar Prabhash, Suresh H. Advani, Ullas Batra, Bivas Biswas, Anuradha Chougule, Mithua Ghosh, Vamshi Krishna Muddu, T. P. Sahoo, Ashok K. Vaid. Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing. Advances in Therapy 2019; 36(4): 766 doi: 10.1007/s12325-019-00903-y
|
| 2 |
Jian Xiong, Rui Wang, Yihua Sun, Haiquan Chen. Clinical analysis of sixty‐four patients with T1aN2M0 stage non‐small cell lung cancer who had undergone resection. Thoracic Cancer 2016; 7(2): 215 doi: 10.1111/1759-7714.12314
|
| 3 |
Yong Dong, Qijun Li, Qian Miao, Da Li. Erlotinib as a salvage treatment after gefitinib failure for advanced non-small-cell lung cancer patients with brain metastasis. Medicine 2021; 100(25): e26450 doi: 10.1097/MD.0000000000026450
|
| 4 |
Jung-min Yang, Kwon-jun Jang, Woo-seok Hwang. A Case Report of Recurrent L858R Mutation Non-Small-Cell Lung Cancer with Brain Metastases Treated with Erlotinib and Traditional Korean Medicine After Failure with Gefitinib. The Journal of Internal Korean Medicine 2022; 43(5): 838 doi: 10.22246/jikm.2022.43.5.838
|
| 5 |
Fangfang Jian, Yanan Cao, Liuguan Bian, Qingfang Sun. USP8: a novel therapeutic target for Cushing’s disease. Endocrine 2015; 50(2): 292 doi: 10.1007/s12020-015-0682-y
|
| 6 |
Lakshimikant Baburao Yenge, Digambar Behera, Mandeep Garg, Ashutosh Nath Aggarwal, Navneet Singh. Comparison of Symptom Score and Bronchoscopy-Based Assessment With Conventional Computed Tomography–Based Assessment of Response to Chemotherapy in Lung Cancer. Journal of Global Oncology 2017; 3(4): 370 doi: 10.1200/JGO.2016.006593
|
| 7 |
Gaetano Romano. Tumor markers currently utilized in cancer care. Materials and Methods 2015; 5 doi: 10.13070/mm.en.5.1456
|